SPAGO NANOMEDICAL (Germany) Performance
| 7UX Stock | EUR 0.02 0 8.99% |
On a scale of 0 to 100, SPAGO NANOMEDICAL holds a performance score of 7. The entity owns a Beta (Systematic Risk) of -0.44, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning SPAGO NANOMEDICAL are expected to decrease at a much lower rate. During the bear market, SPAGO NANOMEDICAL is likely to outperform the market. Please check SPAGO NANOMEDICAL's jensen alpha, maximum drawdown, and the relationship between the coefficient of variation and sortino ratio , to make a quick decision on whether SPAGO NANOMEDICAL's current price history will revert.
Risk-Adjusted Performance
7 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in SPAGO NANOMEDICAL AB are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, SPAGO NANOMEDICAL reported solid returns over the last few months and may actually be approaching a breakup point. ...more
SPAGO |
SPAGO NANOMEDICAL Relative Risk vs. Return Landscape
If you would invest 1.50 in SPAGO NANOMEDICAL AB on November 3, 2024 and sell it today you would earn a total of 0.44 from holding SPAGO NANOMEDICAL AB or generate 29.33% return on investment over 90 days. SPAGO NANOMEDICAL AB is currently producing 0.5947% returns and takes up 5.9466% volatility of returns over 90 trading days. Put another way, 52% of traded stocks are less volatile than SPAGO, and 89% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
SPAGO NANOMEDICAL Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for SPAGO NANOMEDICAL's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as SPAGO NANOMEDICAL AB, and traders can use it to determine the average amount a SPAGO NANOMEDICAL's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 7UX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.95 actual daily | 53 53% of assets are less volatile |
Expected Return
| 0.59 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average SPAGO NANOMEDICAL is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of SPAGO NANOMEDICAL by adding it to a well-diversified portfolio.
SPAGO NANOMEDICAL Fundamentals Growth
SPAGO Stock prices reflect investors' perceptions of the future prospects and financial health of SPAGO NANOMEDICAL, and SPAGO NANOMEDICAL fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on SPAGO Stock performance.
| Return On Equity | -0.19 | |||
| Return On Asset | -0.12 | |||
| Shares Outstanding | 90.94 M | |||
About SPAGO NANOMEDICAL Performance
By analyzing SPAGO NANOMEDICAL's fundamental ratios, stakeholders can gain valuable insights into SPAGO NANOMEDICAL's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if SPAGO NANOMEDICAL has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if SPAGO NANOMEDICAL has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Spago Nanomedical AB develops nanomaterials for cancer diagnostics and treatment. Spago Nanomedical AB was founded in 2007 and is based in Lund, Sweden. SPAGO NANOMEDICAL is traded on Frankfurt Stock Exchange in Germany.Things to note about SPAGO NANOMEDICAL performance evaluation
Checking the ongoing alerts about SPAGO NANOMEDICAL for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for SPAGO NANOMEDICAL help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| SPAGO NANOMEDICAL is way too risky over 90 days horizon | |
| SPAGO NANOMEDICAL has some characteristics of a very speculative penny stock | |
| SPAGO NANOMEDICAL appears to be risky and price may revert if volatility continues | |
| SPAGO NANOMEDICAL has high likelihood to experience some financial distress in the next 2 years | |
| About 26.0% of the company shares are owned by insiders or employees |
- Analyzing SPAGO NANOMEDICAL's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether SPAGO NANOMEDICAL's stock is overvalued or undervalued compared to its peers.
- Examining SPAGO NANOMEDICAL's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating SPAGO NANOMEDICAL's management team can have a significant impact on its success or failure. Reviewing the track record and experience of SPAGO NANOMEDICAL's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of SPAGO NANOMEDICAL's stock. These opinions can provide insight into SPAGO NANOMEDICAL's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for SPAGO Stock analysis
When running SPAGO NANOMEDICAL's price analysis, check to measure SPAGO NANOMEDICAL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SPAGO NANOMEDICAL is operating at the current time. Most of SPAGO NANOMEDICAL's value examination focuses on studying past and present price action to predict the probability of SPAGO NANOMEDICAL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SPAGO NANOMEDICAL's price. Additionally, you may evaluate how the addition of SPAGO NANOMEDICAL to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |